Viewing StudyNCT03816163



Ignite Creation Date: 2024-05-06 @ 12:39 PM
Last Modification Date: 2024-10-26 @ 1:02 PM
Study NCT ID: NCT03816163
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-09
First Post: 2019-01-23

Brief Title: A Study of Zolbetuximab IMAB362 in Adults With Pancreatic Cancer
Sponsor: Astellas Pharma Global Development Inc
Organization: Astellas Pharma Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-03-15
Start Date Type: ACTUAL
Primary Completion Date: 2024-09-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-04-30
Completion Date Type: ESTIMATED
First Submit Date: 2019-01-23
First Submit QC Date: January 23 2019
Study First Post Date: 2019-01-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-13
Last Update Post Date: 2024-07-09
Last Update Post Date Type: ACTUAL